This prospective, population-based study examines the incidence, clinical presentation, and prognosis of infectious encephalitis among adults in Denmark: www.clinicalmicrobiologyandinfection.org/article/S119...
Clinical Microbiology and Infection
@cmijournal.bsky.social
CMI, the official publication of ESCMID, is a monthly peer-reviewed medical journal publishing applied and basic research in the field of clinical microbiology and infectious diseases #IDSky #MicroSky https://www.clinicalmicrobiologyandinfection.com/
This review explores why MICs can vary between methods, highlights key sources of testing discordance, and discusses clinically important phenomena such as tolerance and heteroresistance that standard MIC testing may miss: www.clinicalmicrobiologyandinfection.org/article/S119...
New original article demonstrates that DENOVA supports risk stratification for IE in patients with EfB, informing clinical decision-making and use of transoesophageal echocardiography. Read the full article: www.clinicalmicrobiologyandinfection.org/article/S119...
Strengthen your clinical research skills at this onsite course. Explore study design, bias reduction, scientific writing, and the latest developments in clinical trial methodology through practical, project-based learning. Learn more & sign up today! ow.ly/nC9l50Zb6nM
📣 In the July 2026 issue: Association between early SARS-CoV-2 viral rebound and post-COVID conditions among immunocompromised patients: cohort study www.clinicalmicrobiologyandinfection.org/article/S119... #covid #IDSky #MicroSky
📣 New Supplement publication in CMI The role of whole genome sequencing in antimicrobial susceptibility prediction of bacteria: 2025 update from the #EUCAST Subcommittee @escmid.bsky.social Read here: www.clinicalmicrobiologyandinfection.org/article/S119...
🌟 The 2025 JCR Impact Factor for CMI has risen to 8.7! We thank our editors, reviewers, authors and readers for their dedication and extraordinary work. Read about how CMI did in 2025 here: clinicalmicrobiologyandinfection.org/article/S119... #IDSky #MicroSky #JIF #JCR2025
📣 Deadline for the open call to join the CMI editorial board as an editor in virology is July 31st! Learn more about the qualifications and expectations of the role, and how to apply in the editorial note: ow.ly/iVSJ50YUtvb
The DNA vaccine candidate INO-4201 demonstrated good safety and immunogenicity in healthy adult volunteers primed with rVSVΔG-ZEBOV-GP. Read the full article here: www.clinicalmicrobiologyandinfection.org/article/S119... #vaccine #publichealth #clinicaltrial #globalhealth
Strengthen your clinical research skills at this onsite course. Explore study design, bias reduction, scientific writing, and the latest developments in clinical trial methodology through practical, project-based learning. Learn more & sign up today! ow.ly/nC9l50Zb6nM
New review shows TLR polymorphisms linked to increased risk of fungal infection (OR 1.90). Key players: TLR2, TLR4, TLR9. Read the full article: www.clinicalmicrobiologyandinfection.org/article/S119... #IDsky
How could we define the best treatment duration for immunocompromised hosts? Happy to share our perspective in this editorial in @cmijournal.bsky.social, building on the recent BALANCE subanalysis for this vulnerable population www.sciencedirect.com/science/arti... #AMSsky #TxID #IDOnc #IDsky
sciencedirect.com
📣 In the July 2026 issue: Guiding principles for implementing ESCMID clinical practice guidelines www.clinicalmicrobiologyandinfection.org/article/S119... @escmid.bsky.social
New in @cmijournal.bsky.social: "Which trial do we need? Evaluating plasma microbial cell-free DNA in blood culture-negative infective endocarditis" #IDSky @absteward.bsky.social www.clinicalmicrobiologyandinfection.org/article/S119...
A practical “How to” guide for laboratories, researchers, and AST developers working with EUCAST breakpoints. Read here: www.clinicalmicrobiologyandinfection.org/article/S119... #EUCAST #AST #AMR #Microbiology #IDSky #MicroSky #AntimicrobialResistance
In this latest @escmid.bsky.social clinical guideline, a panel of 16 multidisciplinary experts provide recommendations for how to evaluate and manage patients with reported antibiotic allergies. www.clinicalmicrobiologyandinfection.org/article/S119...
📣 New publication: First reported case of Andes hantavirus cardiopulmonary syndrome treated with a combination of favipiravir, ribavirin, icatibant and baricitinib: www.clinicalmicrobiologyandinfection.org/article/S119... #hantavirus
Bundibugyo ebolavirus outbreak in the Democratic Republic of the Congo and Uganda: rapid assessment from the ESCMID Emerging Infections Subcommittee @cmijournal.bsky.social @escmid.bsky.social www.clinicalmicrobiologyandinfection.org/article/S119...
Bundibugyo ebolavirus outbreak in the Democratic Republic of the Congo and Uganda: rapid assessment from the ESCMID Emerging Infections Subcommittee
The ongoing outbreak of Ebola virus disease (EVD) caused by Bundibugyo ebolavirus (BDBV) in the Democratic Republic of the Congo (DRC) and Uganda represents a major regional public health emergency wi...
clinicalmicrobiologyandinfection.org
In this study, Pinot et al assessed whether chest X-ray and/or C-reactive protein testing could influence antibiotic initiation among French general practitioners managing outpatients with suspected community-acquired pneumonia: www.clinicalmicrobiologyandinfection.org/article/S119...
💥🆕”Can Influenza Virus Cause Bacteremia, Sepsis, and Septic Shock?” Out today 👇Free bit.ly/3PWNDYu @unmc-id.bsky.social @criticalcarereviews.com #IDSky #MedSky #PCCSky #ICUSky #EMIMCC #Ansky #EMSky#ClinMicro @cidjournal.bsky.social @cmijournal.bsky.social @cmicomms.bsky.social @kcawcutt.bsky.social
Can Influenza Virus Cause Bacteremia, Sepsis, and Septic Shock?
Viral–bacterial respiratory coinfections have been reported for more than a century, including during the 1918 influenza pandemic [1]. However, only recent
bit.ly
📣 In the June 2026 issue: Monotherapy vs. combination therapy for Enterococcus faecalis bacteraemia: a target trial emulation www.clinicalmicrobiologyandinfection.org/article/S119...
📣 New publication: Andes hantavirus outbreak on a cruise ship - an ESCMID Emerging Infections Subcommittee (EIS) rapid assessment www.clinicalmicrobiologyandinfection.org/article/S119...
Andes hantavirus outbreak on a cruise ship - an ESCMID Emerging Infections Subcommittee (EIS) rapid assessment
The ongoing cluster of hantavirus infections associated with the cruise ship MV Hondius represents an unusual but instructive event at the intersection of zoonotic spillover, human mobility, confined ...
clinicalmicrobiologyandinfection.org
✏️Clinical Microbiology and Infection (CMI) is looking for an editor in virology to join our editorial board. 💡Learn more about the qualifications and expectations of the role, and how to apply in the editorial note: ow.ly/iVSJ50YUtvb
Looking forward to seeing you at this exciting ESCMID Late-breaking session on Sunday 👇👇 @escmid.bsky.social @cmijournal.bsky.social @cmicomms.bsky.social @unmc-id.bsky.social #IDSky #MedSky #PCCSky #ICUSky #EMIMCC #Ansky #EMSky #AMSSky #TxID #meded #Pharmsky #Pharmed #RXSky #MicroSky #ClinMicro
Revisiting tuberculosis diagnostics: progress, pitfalls, and future directions #IDSky #TBSky @cmijournal.bsky.social www.clinicalmicrobiologyandinfection.org/article/S119...
Revisiting tuberculosis diagnostics: progress, pitfalls, and future directions
Tuberculosis (TB) continues to pose a significant global health threat, claiming ∼1.25 million lives in 2023 [1]. Timely diagnosis is essential for treatment and transmission control, yet it remains the weakest link in TB care, with millions of cases undetected each year [2].
clinicalmicrobiologyandinfection.org
